Posttranslational Acetylation of the Human Immunodeficiency Virus Type 1 Integrase Carboxyl-Terminal Domain Is Dispensable for Viral Replication
Open Access
- 15 March 2007
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 81 (6) , 3012-3017
- https://doi.org/10.1128/jvi.02257-06
Abstract
A recent report sought to demonstrate that acetylation of specific lysines within integrase (IN) by the histone acetyltransferase (HAT) p300 regulates human immunodeficiency virus type 1 (HIV-1) integration and is essential for viral replication (A. Cereseto, L. Manganaro, M. I. Gutierrez, M. Terreni, A. Fittipaldi, M. Lusic, A. Marcello, and M. Giacca, EMBO J. 24:3070-3081, 2005). We can corroborate the efficient and specific acetylation of the IN carboxyl-terminal domain (CTD) (amino acids 212 to 288) by p300 using purified recombinant components. Although arginine substitution mutagenesis of the isolated CTD confirms that the majority of p300 acetylation occurs at lysine residues 264, 266, and 273, the pattern of acetylation is not uniform and a hierarchy of reactivity can be established. Several combinatorial mutations of the CTD lysines modified by p300 in vitro were reconstructed into an otherwise infectious proviral plasmid clone and examined for viral growth and frequency of productive chromosomal integration. In contrast to the findings of Cereseto and coworkers, who used epitope-tagged viruses for their experiments, we find that an untagged mutant virus, IN K(264/266/273)R, is fully replication competent. This discrepancy may be explained by the use of an acidic epitope tag placed at the extreme carboxyl terminus of integrase, near the target site for acetylation. Although the tagged, wild-type virus is viable, the combination of this epitope tag with the RRR substitution mutation results in a replication-defective phenotype. Although IN belongs to the very small set of nonhistone proteins modified by HAT-mediated activity, an obligate role for acetylation at the reactive CTD lysines in HIV-1 IN cannot be confirmed.Keywords
This publication has 58 references indexed in Scilit:
- Mutational Alteration of Human Immunodeficiency Virus Type 1 Vif Allows for Functional Interaction with Nonhuman Primate APOBEC3GJournal of Virology, 2006
- Differential Requirement for Conserved Tryptophans in Human Immunodeficiency Virus Type 1 Vif for the Selective Suppression of APOBEC3G and APOBEC3FJournal of Virology, 2006
- Molecular dynamics studies of the full-length integrase–DNA complexBiochemical and Biophysical Research Communications, 2005
- Genetic Analyses of Conserved Residues in the Carboxyl-Terminal Domain of Human Immunodeficiency Virus Type 1 IntegraseJournal of Virology, 2005
- Histone Acetyltransferase Activity of p300 Is Required for Transcriptional Repression by the Promyelocytic Leukemia Zinc Finger ProteinMolecular and Cellular Biology, 2005
- Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 ReplicationJournal of Virology, 2004
- Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif proteinNature, 2002
- Regulation of Transcription Factor YY1 by Acetylation and DeacetylationMolecular and Cellular Biology, 2001
- The DNA-binding domain of HIV-1 integrase has an SH3-like foldNature Structural & Molecular Biology, 1995
- Localization of DNA Binding Activity of HIV-1 Integrase to the C-Terminal Half of the ProteinAIDS Research and Human Retroviruses, 1992